Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
PR Newswire (May 8, 2013)
-
-
-
-
-
PR Newswire (Apr 30, 2013)
-
-
-
-
-
-
PR Newswire (Apr 15, 2013)
-
-
-
-
PR Newswire (May 8, 2013)
-
at CNBC.com (Apr 30, 2013)
-
PR Newswire (Apr 30, 2013)
-
PR Newswire (Apr 15, 2013)
-
at CNBC.com (Mar 6, 2013)
-
PR Newswire (Feb 26, 2013)
-
PR Newswire (Feb 6, 2013)
-
PR Newswire (Jan 3, 2013)
-
at MarketWatch.com (Jan 2, 2013)
-
PR Newswire (Jan 2, 2013)
-
at MarketWatch.com (Dec 27, 2012)
-
PR Newswire (Dec 4, 2012)
-
PR Newswire (Dec 3, 2012)
-
PR Newswire (Dec 3, 2012)
-
at CNBC.com (Nov 29, 2012)
-
PR Newswire (Oct 23, 2012)
-
PR Newswire (Oct 15, 2012)
-
at CNBC.com (Oct 9, 2012)
-
at CNBC.com (Oct 8, 2012)
QCOR vs. ETF Alternatives
Company Description
We market H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved for the treatment of certain disorders with an inflammatory component, including the treatment of exacerbations associated with multiple sclerosis (“MS”), and the treatment of nephrotic syndrome.... More
